Heng Lin
Research Assistant Professor
Surgery
[email protected]

Available to mentor

Heng Lin
Research Assistant Professor
  • Recent Publications
  • Recent Publications See All Publications
    • Journal Article
      PIKfyve, expressed by CD11c-positive cells, controls tumor immunity.
      Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC-Y, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, Vatan L, Lin H, Li G, Zheng Y, Zhang Y, Cao X, Su F, Wang R, He T, Cieslik M, Green MD, Zou W, Chinnaiyan AM. Nat Commun, 2024 Jun 28; 15 (1): 5487 DOI:10.1038/s41467-024-48931-9
      PMID: 38942798
    • Journal Article
      Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance.
      Yu J, Yan Y, Li S, Xu Y, Parolia A, Rizvi S, Wang W, Zhai Y, Xiao R, Li X, Liao P, Zhou J, Okla K, Lin H, Lin X, Grove S, Wei S, Vatan L, Hu J, Szumilo J, Kotarski J, Freeman ZT, Skala S, Wicha M, Cho KR, Chinnaiyan AM, Schon S, Wen F, Kryczek I, Wang S, Chen L, Zou W. Cell, 2024 Aug 22; 187 (17): 4713 - 4732.e19. DOI:10.1016/j.cell.2024.06.012
      PMID: 38968937
    • Journal Article
      PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages.
      Pitter MR, Kryczek I, Zhang H, Nagarsheth N, Xia H, Wu Z, Tian Y, Okla K, Liao P, Wang W, Zhou J, Li G, Lin H, Vatan L, Grove S, Wei S, Li Y, Zou W. Cell Rep, 2024 Mar 26; 43 (3): 113942 DOI:10.1016/j.celrep.2024.113942
      PMID: 38489266
    • Journal Article
      PIKfyve controls dendritic cell function and tumor immunity.
      Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC-Y, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, Vatan L, Lin H, Li G, Zheng Y, Zhang Y, Cao X, Su F, Wang R, He T, Cieslik M, Green MD, Zou W, Chinnaiyan AM. bioRxiv, 2024 Jul 1; DOI:10.1101/2024.02.28.582543
      PMID: 38464258
    • Presentation
      Macrophages endow tumor resistance to ferroptosis.
      Lin H. 2023 May 26;
    • Journal Article
      LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy.
      Li G, Kryczek I, Nam J, Li X, Li S, Li J, Wei S, Grove S, Vatan L, Zhou J, Du W, Lin H, Wang T, Subramanian C, Moon JJ, Cieslik M, Cohen M, Zou W. Nat Cell Biol, 2021 May; 23 (5): 526 - 537. DOI:10.1038/s41556-021-00672-3
      PMID: 33958760
    • Journal Article
      Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance.
      Lin H, Kryczek I, Li S, Green MD, Ali A, Hamasha R, Wei S, Vatan L, Szeliga W, Grove S, Li X, Li J, Wang W, Yan Y, Choi JE, Li G, Bian Y, Xu Y, Zhou J, Yu J, Xia H, Wang W, Alva A, Chinnaiyan AM, Cieslik M, Zou W. Cancer Cell, 2021 Apr 12; 39 (4): 480 - 493.e6. DOI:10.1016/j.ccell.2020.12.023
      PMID: 33513345
    • Journal Article
      The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity.
      Zhou J, Kryczek I, Li S, Li X, Aguilar A, Wei S, Grove S, Vatan L, Yu J, Yan Y, Liao P, Lin H, Li J, Li G, Du W, Wang W, Lang X, Wang W, Wang S, Zou W. Nat Immunol, 2021 Apr; 22 (4): 460 - 470. DOI:10.1038/s41590-021-00888-3
      PMID: 33767425